142 related articles for article (PubMed ID: 29395168)
21. Recurrence rate of basal cell carcinoma after topical aminolevulinic acid-based photodynamic therapy.
Naidenov N; Dencheva R; Tsankov N
Acta Dermatovenerol Croat; 2004; 12(3):157-61. PubMed ID: 15369639
[TBL] [Abstract][Full Text] [Related]
22. Nodular basal cell carcinoma: when in doubt, cut it out.
Brownell I
J Drugs Dermatol; 2007 Dec; 6(12):1245-6. PubMed ID: 18189068
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
[TBL] [Abstract][Full Text] [Related]
24. Sequential treatment of giant basal cell carcinomas.
Madan V; West CA; Murphy JV; Lear JT
J Plast Reconstr Aesthet Surg; 2009 Oct; 62(10):e368-72. PubMed ID: 18572004
[TBL] [Abstract][Full Text] [Related]
25. Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.
Morton C; Horn M; Leman J; Tack B; Bedane C; Tjioe M; Ibbotson S; Khemis A; Wolf P
Arch Dermatol; 2006 Jun; 142(6):729-35. PubMed ID: 16785375
[TBL] [Abstract][Full Text] [Related]
26. Treating basal-cell carcinoma in a real life setting.
Dummer R
Lancet Oncol; 2013 Jun; 14(7):572-3. PubMed ID: 23683749
[No Abstract] [Full Text] [Related]
27. Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment.
Essers BAB; Arits AH; Hendriks MR; Mosterd K; Kelleners-Smeets NW
Br J Dermatol; 2018 Jan; 178(1):e26-e27. PubMed ID: 28667739
[No Abstract] [Full Text] [Related]
28. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
[TBL] [Abstract][Full Text] [Related]
29. Methyl aminolevulinate-photodynamic therapy for basal cell carcinoma.
Szeimies RM
Dermatol Clin; 2007 Jan; 25(1):89-94. PubMed ID: 17126746
[TBL] [Abstract][Full Text] [Related]
30. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
31. Complete remission of two patients with recurrent and wide spread extramammary Paget disease obtained from 5-aminolevulinic acid-based photodynamic therapy and imiquimod combination treatment.
Jing W; Juan X; Li X; Jiayuan C; Qin H; Qing L; Shengmei X
Photodiagnosis Photodyn Ther; 2014 Sep; 11(3):434-40. PubMed ID: 24657920
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion.
Hürlimann AF; Hänggi G; Panizzon RG
Dermatology; 1998; 197(3):248-54. PubMed ID: 9812030
[TBL] [Abstract][Full Text] [Related]
33. Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial.
Rhodes LE; de Rie M; Enström Y; Groves R; Morken T; Goulden V; Wong GA; Grob JJ; Varma S; Wolf P
Arch Dermatol; 2004 Jan; 140(1):17-23. PubMed ID: 14732655
[TBL] [Abstract][Full Text] [Related]
34. Long-term follow-up of patients with basal cell carcinoma after successful treatment with intralesional photodynamic therapy.
Suárez Valladares MJ; Pérez Paredes MG; González Sixto B; Rodríguez Prieto MÁ
J Am Acad Dermatol; 2016 Dec; 75(6):e247. PubMed ID: 27846979
[No Abstract] [Full Text] [Related]
35. Fractionated 5-aminolevulinic acid photodynamic therapy in the treatment of a giant recurrent superficial basal cell carcinoma.
Sotiriou E; Apalla Z; Ioannides D
Photodermatol Photoimmunol Photomed; 2009 Dec; 25(6):331-2. PubMed ID: 19906170
[No Abstract] [Full Text] [Related]
36. A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8-20 mm), with a 12-month follow-up.
Szeimies RM; Ibbotson S; Murrell DF; Rubel D; Frambach Y; de Berker D; Dummer R; Kerrouche N; Villemagne H;
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1302-11. PubMed ID: 18624836
[TBL] [Abstract][Full Text] [Related]
37. Comparing ablative fractionated resurfacing, photodynamic therapy, and topical imiquimod in the treatment of trichoblastomas of Brooke-Spiegler Syndrome: a case study.
LoPiccolo MC; Sage RJ; Kouba DJ
Dermatol Surg; 2011 Jul; 37(7):1047-50. PubMed ID: 21388481
[No Abstract] [Full Text] [Related]
38. Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors?
Ruiz ES; Cohen JL; Friedman A
J Drugs Dermatol; 2015 May; 14(5):450-2. PubMed ID: 25942661
[TBL] [Abstract][Full Text] [Related]
39. A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: clinical and histologic outcomes.
Serra-Guillén C; Nagore E; Hueso L; Traves V; Messeguer F; Sanmartín O; Llombart B; Requena C; Botella-Estrada R; Guillén C
J Am Acad Dermatol; 2012 Apr; 66(4):e131-7. PubMed ID: 22226430
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of recurrence after photodynamic therapy with topical methylaminolaevulinate for 157 basal cell carcinomas in 90 patients.
Lindberg-Larsen R; Sølvsten H; Kragballe K
Acta Derm Venereol; 2012 Mar; 92(2):144-7. PubMed ID: 21918794
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
